Sandoz Canada Inc.
Registration:
24
of
33
(2021-06-03
to
2022-01-07)
Senior Officers whose lobbying activities represent less than 20% of their Duties
-
Mauricio Ede,
Chief Medical & Scientific Officer
-
Marc-André Huot,
Directeur des brevets
-
Carmen Pedro,
Director, Market Access Biosimilars
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
-
Guillaume Lefebvre,
Director, Government Affairs
- Date Modified: